Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts that cover Corcept Therapeutics stock have a consensus rating of "Buy" and an average price target of $111, which forecasts a 168.77% increase in the stock price over the next year. The lowest target is $90 and the highest is $150.

Price Target: $111 (+168.77%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$90	$111	$99	$150
Change	+117.92%	+168.77%	+139.71%	+263.20%

Analyst Ratings

The average analyst rating for Corcept Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26
Strong Buy	3	3	3	3	3	3
Buy	1	1	1	1	1	1
Hold	0	0	0	1	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	5	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $140 → $99	Strong Buy	Maintains	$140 → $99	+139.71%	Jan 2, 2026
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $145 → $90	Strong Buy	Maintains	$145 → $90	+117.92%	Jan 2, 2026
Ashwani Verma UBS	UBS	Hold Initiates $95	Hold	Initiates	$95	+130.02%	Dec 16, 2025
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $145	Strong Buy	Reiterates	$145	+251.09%	Nov 25, 2025
Kalpit Patel Wolfe Research	Wolfe Research	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Nov 18, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

821.49M

Increased by 21.70%

from 675.04M

Revenue Next Year

1.07B

Increased by 30.13%

from 821.49M

EPS This Year

0.89

Decreased by -27.85%

from 1.23

EPS Next Year

0.50

Decreased by -43.45%

from 0.89

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	353.87M	365.98M	401.86M	482.38M	675.04M	821.49M	1.07B
Revenue Growth	15.46%	3.42%	9.80%	20.04%	39.94%	21.70%	30.13%
EPS	0.85	0.89	0.87	0.94	1.23	0.89	0.50
EPS Growth	10.39%	4.71%	-2.25%	8.05%	30.85%	-27.85%	-43.45%
Forward PE	-	-	-	-	-	46.54	82.30
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	866.3M	1.3B
Avg	821.5M	1.1B
Low	741.5M	826.1M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	28.3%	61.4%
Avg	21.7%	30.1%
Low	9.8%	0.6%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	1.24	1.50
Avg	0.89	0.50
Low	0.56	-0.91

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	0.7%	69.2%
Avg	-27.9%	-43.4%
Low	-54.6%	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.